Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

Phase 3CompletedNCT00681980

University of Sao Paulo60 enrolled

Overview

Is the valproic acid efficacy to treat TSP/HAM

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

15 mg/kg/day

metypredsolone 1 g/day

valporid acid 15 mg/kg/day plus corticosteroids 1 g/patient

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * HTLV-1; TSP/HAM fulfill criteria Exclusion Criteria: * Age \<18 years

Institute of Tropical Medicine at Sao Paulo University

São Paulo, São Paulo, Brazil

Neurological sacles

Time frame: 24 months

Quality of life

Time frame: 2009

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.